ÂÜÀòÂÒÂ×

Rajeev Dham

Investor at Verse Medical

Rajeev Dham serves as the Managing Director at Sapphire since July 2013 and has extensive experience as an investor across multiple companies, including Glean, Supio, Constructor, Creatio, Verse, BioCatch, Qualified, CaptivateIQ, and Paper, with roles commencing between 2022 and 2024. Rajeev holds a BS in Business Administration from the USC Marshall School of Business and an MBA from Harvard Business School, complemented by an education from Mission San Jose High School.

Links